Literature DB >> 8156624

Cardiovascular development. Prospects for a genetic approach.

M C Fishman1, D Y Stainier.   

Abstract

Genetics is a powerful tool, especially when used in combination with embryology, in the seeking of genes necessary for assembly of the cardiovasculature. The first questions must address the types of cellular decisions that are made during development. As for simpler systems in C elegans and D melanogaster, the lineage and cell-fate decisions of the cardiovascular progenitors need to be assessed. In addition it is likely that new paradigms will emerge for multicellular assembly. The study of cardiovascular mutations will define individual genetic steps that define organotypic decisions. A genetic approach is a natural extension of embryology, physiology, and anatomy, fields of great sophistication with regard to the cardiovasculature, because, like them, it focuses on integrative biology and on the intact organism. The zebrafish is particularly well suited to a combination genetic-embryologic study of the fashioning of the cardiovasculature.

Entities:  

Mesh:

Year:  1994        PMID: 8156624     DOI: 10.1161/01.res.74.5.757

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

1.  Harnessing fetal and adult genetic reprograming for therapy of heart disease.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  J Nat Sci       Date:  2015-04

2.  Assessment of strain and strain rate in embryonic chick heart in vivo using tissue Doppler optical coherence tomography.

Authors:  Peng Li; Aiping Liu; Liang Shi; Xin Yin; Sandra Rugonyi; Ruikang K Wang
Journal:  Phys Med Biol       Date:  2011-10-21       Impact factor: 3.609

3.  UDP-glucose dehydrogenase polymorphisms from patients with congenital heart valve defects disrupt enzyme stability and quaternary assembly.

Authors:  Annastasia S Hyde; Erin L Farmer; Katherine E Easley; Kristy van Lammeren; Vincent M Christoffels; Joseph J Barycki; Jeroen Bakkers; Melanie A Simpson
Journal:  J Biol Chem       Date:  2012-07-18       Impact factor: 5.157

4.  Measurement of strain and strain rate in embryonic chick heart in vivo using spectral domain optical coherence tomography.

Authors:  Peng Li; Xin Yin; Liang Shi; Aiping Liu; Sandra Rugonyi; Ruikang Wang
Journal:  IEEE Trans Biomed Eng       Date:  2011-05-12       Impact factor: 4.538

5.  Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.

Authors:  Q Lin; J Schwarz; C Bucana; E N Olson
Journal:  Science       Date:  1997-05-30       Impact factor: 47.728

Review 6.  The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations.

Authors:  Jan M Spitsbergen; Michael L Kent
Journal:  Toxicol Pathol       Date:  2003 Jan-Feb       Impact factor: 1.902

Review 7.  Systematizing serendipity for cardiovascular drug discovery.

Authors:  Peter J Schlueter; Randall T Peterson
Journal:  Circulation       Date:  2009-07-21       Impact factor: 29.690

8.  Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1.

Authors:  Y Kurihara; H Kurihara; H Oda; K Maemura; R Nagai; T Ishikawa; Y Yazaki
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Expression of cardiac muscle markers in rat myocyte cell lines.

Authors:  G L Engelmann; R A Worrell; R A Duff; P S Grutkoski; K R Chien; R P Harvey
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

10.  A zebrafish model of conditional targeted podocyte ablation and regeneration.

Authors:  Jianmin Huang; Mary McKee; Hong D Huang; Alice Xiang; Alan J Davidson; Hua A J Lu
Journal:  Kidney Int       Date:  2013-03-06       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.